George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,176.00
Bid: 12,176.00
Ask: 12,178.00
Change: 188.00 (1.57%)
Spread: 2.00 (0.016%)
Open: 12,254.00
High: 12,256.00
Low: 12,052.00
Prev. Close: 11,988.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Euro zone bonds hold ground, eyeing vaccinations, Fed

Tue, 16th Mar 2021 09:11

* Vaccine hurdles, Fed meeting support euro zone government
bonds

* France starts sale of new green bond

By Yoruk Bahceli

AMSTERDAM, March 16 (Reuters) - Euro zone government bonds
held ground in early Tuesday trade, as caution set in before a
U.S. Federal Reserve meeting and uncertainty around vaccinations
in the bloc supported safe-haven assets.

Wednesday's Fed meeting is in focus amid expectations that
economic growth and inflation will rebound after U.S. fiscal
stimulus, which has pushed up government bond yields across the
world in recent weeks. The Fed so far has been downplaying those
concerns.

Safe-haven euro zone government bonds were also supported by
concerns around the bloc's vaccination efforts -- which already
lag the U.S. and Britain -- after Europe's largest economies
temporarily halted the use of AstraZeneca's vaccine on
Monday

The vaccine currently encompasses around 25% of the vaccines
distributed across the European Union, and 15% of those so far
administered, according to Mizuho analysts.

Uncertainty around the AstraZeneca vaccine rollout "adds to
the general theme that the Eurozone is lagging behind in the
recovery from the pandemic," ING analysts told clients.

On Tuesday, Germany's 10-year yield, the benchmark for the
euro area, was unchanged at -0.34% at 0829 GMT, below the
highest since March 2020 around -0.20% touched in late February.
Bond yields move inversely with prices.

The gap between 10-year German and U.S. Treasury yields --
an indicator that reflects the divergence between safe-haven
assets in the euro area and the United States -- remains just
shy of its highest since February 2020, as U.S. yields have
continued to rise this month while German Bund yields have
fallen.

In the primary market, France started the sale of its second
green bond via a syndicate of banks.

UniCredit analysts expect France to raise around 8 billion
euros from the deal, more than the 7 billion euros it raised
when it issued its first green bond in 2017, given higher
borrowing needs due to the pandemic and the popularity of
environmentally friendly assets.

Elsewhere, Germany and Finland will re-open existing bonds
via auction.
(Reporting by Yoruk Bahceli, editing by Larry King)

More News
Today 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
Today 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
Today 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
Today 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.